Biorepository for Adverse Drug Reaction (RADR)
E
Emma Tillman
Primary Investigator
Enrolling By Invitation
1-100 years
All
Phase
N/A
10000 participants needed
3 Locations
Brief description of study
The primary objective of the Biorepository for Adverse Drug Reaction (RADR) will be to provide researchers with a bank of biological samples and clinical data related to investigate biomarkers of unexpected response following medicines and vaccines.
Detailed description of study
Collection of blood samples from adults and children, with consideration to the age, weight, and health of the subjects, along with the collection procedure, the amount of blood to be collected and the frequency of collection. Amount drawn will not exceed the lesser of 50 ml or 3 ml per kg in an 8 week period and collection will not occur more frequently than 2 times per week.
Eligibility of study
You may be eligible for this study if you meet the following criteria:
- Conditions: Adverse Drug Reaction, Biorepository
-
Age: Between 1 Years - 100 Years
-
Gender: All
Inclusion Criteria:
- • Patients who have experienced ADR to a medicine or vaccine.
- • Family member of a patient who experienced ADR to a medicine or vaccine.
Exclusion Criteria:
- N/A
Updated on
01 Aug 2024.
Study ID: 2005586343
Please visit our main page to search for other studies you may be interested in.
If you need help finding a study or have any questions, please contact us at inhealth@iu.edu
